Literature DB >> 10865041

Total thyroidectomy for management of thyroid disease.

I R Gough1, D Wilkinson.   

Abstract

Total thyroidectomy is a logical treatment for many patients with thyroid disease, including patients in whom the pathologic process requiring surgery involves both lobes of the thyroid or the risk of recurrence is a significant consideration, as in benign multinodular goiter, Graves' disease, and cancer. In earlier times the risks of extensive surgery and problems of adequate hormone replacement deterred surgeons from performing total thyroidectomy. However, as we enter the twenty-first century we are confident that the technical aspects of safe total thyroidectomy are established and that thyroid hormone replacement and monitoring are readily available and accurate. In the future total thyroidectomy is likely to be performed increasingly commonly for both benign and malignant disease.

Entities:  

Mesh:

Year:  2000        PMID: 10865041     DOI: 10.1007/s002680010158

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  21 in total

Review 1.  State of the art: surgery for endemic goiter--a plea for individualizing the extent of resection instead of heading for routine total thyroidectomy.

Authors:  Henning Dralle; Kerstin Lorenz; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2011-06-01       Impact factor: 3.445

2.  Alternating from subtotal thyroid resection to total thyroidectomy in the treatment of Graves' disease prevents recurrences but increases the frequency of permanent hypoparathyroidism.

Authors:  Johannes Järhult; Per-Olof Andersson; Linda Duncker
Journal:  Langenbecks Arch Surg       Date:  2011-12-09       Impact factor: 3.445

3.  Five-year follow-up of a randomized clinical trial of total thyroidectomy versus Dunhill operation versus bilateral subtotal thyroidectomy for multinodular nontoxic goiter.

Authors:  Marcin Barczyński; Aleksander Konturek; Alicja Hubalewska-Dydejczyk; Filip Gołkowski; Stanisław Cichoń; Wojciech Nowak
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

4.  Incidence and risk factors for injuries to the recurrent laryngeal nerve during neck surgery in the moderate-volume setting.

Authors:  Kalle Landerholm; Anna-Maria Wasner; Johannes Järhult
Journal:  Langenbecks Arch Surg       Date:  2014-01-09       Impact factor: 3.445

5.  Total versus bilateral subtotal thyroidectomy for benign multi-nodular goiter.

Authors:  Fatih Ciftci; Erdal Sakalli; Ibrahim Abdurrahman
Journal:  Int J Clin Exp Med       Date:  2015-03-15

6.  Differentiated operative strategy in minimally invasive, video-assisted thyroid surgery results in 196 patients.

Authors:  Jochen Schabram; Christian Vorländer; Robert A Wahl
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

7.  Comparison of surgical techniques for treatment of benign toxic multinodular goiter.

Authors:  Orhan Alimoglu; Murat Akdag; Mustafa Sahin; Cagatay Korkut; Ismail Okan; Neslihan Kurtulmus
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

8.  The efficacy and safety of total thyroidectomy in the management of benign thyroid disease: a review of 932 cases.

Authors:  Eleni I Efremidou; Michael S Papageorgiou; Nikolaos Liratzopoulos; Konstantinos J Manolas
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

9.  The change in surgical practice from subtotal to near-total or total thyroidectomy in the treatment of patients with benign multinodular goiter.

Authors:  Serdar Tezelman; Ismail Borucu; Yasemin Senyurek Giles; Fatih Tunca; Tarik Terzioglu
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

10.  Complications of total thyroidectomy performed by surgical residents versus specialist surgeons.

Authors:  Ali U Emre; Güldeniz Karadeniz Cakmak; Oge Tascilar; Bülent H Ucan; Oktay Irkorucu; Kemal Karakaya; Hakan Balbaloglu; Sami Dibeklioglu; Mesut Gul; Handan Ankarali; Mustafa Comert
Journal:  Surg Today       Date:  2008-09-27       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.